期刊文献+

糖尿病视网膜病变黄斑部脉络膜厚度临床分析 被引量:11

Macular choroidal thickness in patients of diabetic retinopathy
原文传递
导出
摘要 目的 观察糖尿病视网膜病变(DR)患者黄斑部脉络膜厚度改变。方法 临床检查确诊的DR患者33例43只眼纳入研究。其中,男性16例20只眼,女性17例23只眼。根据裂隙灯显微镜联合90D前置镜、光相干断层扫描(OCT)检查结果,并依照DR国际分期标准,将患眼分为非增生型DR(NPDR)不伴显著性黄斑囊样水肿(CSME)(NPDR CSME-)组、NPDR伴CSME(NPDR CSME+)组,分别为16、27只眼。选取同期年龄>45岁健康志愿者和血压控制良好且眼底检查正常的高血压患者11例11只眼作为对照组。三组受检者间性别、年龄、眼别、等效球镜度数比较,差异均无统计学意义(χ^2=0.562, F=0.580, χ^2=0.129, F=0.421;P值均>0.05)。采用Topcon 3D OCT-1000仪分别测量各组黄斑中心凹下(C 0.0 mm),通过黄斑中心凹的水平方向距黄斑中心凹鼻侧(N)、颞侧(T)各500、1000、1500、2000、2500 μm处共11个位点的脉络膜厚度,以及黄斑中心凹视网膜厚度。结果 NPDR CSME+组C 0.0 mm、T 0.5 mm、T 1.0 mm、T 1.5 mm、T 2.0 mm、T2.5 mm、N0.5 mm、N 1.5 mm位点脉络膜厚度较对照组变薄,差异有统计学意义(F=3.459、4.605、5.997、9.096、9.777、11.563、3.765、3.339,P<0.05);N1.0 mm、N 2.0 mm、N 2.5 mm位点脉络膜厚度亦较对照组变薄,但差异无统计学意义(F=2.889、3.157、2.194, P>0.05)。NPDR CSME-组各位点脉络膜厚度与对照组各位点脉络膜厚度比较,差异均无统计学意义(F=2.194、3.157、3.339、2.889、3.765、3.459、4.605、5.997、9.096、9.777、11.563,P>0.05)。NPDR CSME+组T2.5 mm、T 2.0 mm、T1.5 mm位点脉络膜厚度与NPDR CSME-组相同位点脉络膜厚度比较,差异有统计学意义(F=11.563、9.777、9.096,P<0.05);两组其余各位点脉络膜厚度比较,差异均无统计学意义(F=2.194、3.157、3.339、2.889、3.765、3.459、4.605、5.997, P>0.05)。相关性分析结果显示,对照组(r=-0.096)、NPDR CSME-组(r=0.026)、NPDR CSME+组(r=-0.067)黄斑中心凹下处脉络膜厚度与黄斑中心凹视网膜厚度无相关(P>0.05)。结论 NPDR黄斑水肿患者黄斑部脉络膜厚度较正常人变薄。 Objective To analyze the choroidal thickness (CT) in patients of diabetic retinopathy (DR). Methods A total of 33 DR patients (43 eyes) were enrolled in this study, including 16 males (20 eyes) and 17 females (23 eyes). They were divided non-proliferative diabetic retinopathy (NPDR) without macular edema (ME) group (NPDR CSME- group, 16 eyes), and NPDR with ME group (NPDR CSME+ group, 27 eyes) in accordance with international DR staging standard. The control group included healthy volunteers (age〉45 years) and hypertension patients with wellcontrolled blood pressure and normal fundus, totally 11 subjects (11 eyes). There was no significant difference between these 3 groups for gender, age, laterality, spherical equivalent degrees (χ^2=0.562, F=0.580, χ^2=0.129, F=0.421;P〉0.05). The CT and foveal retinal thickness were measured by Topcon 3D optical coherence tomography (OCT)1000 at 11 locations, including subfoveal, 5 locations (500, 1000, 1500, 2000, 2500 μm from the foveal) at the nasal or temporal side horizontally. Results The CT was significant thinner for NPDR CSME+ group than control group at 8 locations (subfoveal, T 0.5 mm, T 1.0 mm, T 1.5 mm, T 2.0 mm, T 2.5 mm, N 0.5 mm, N 1.5 mm) (F=3.459, 4.605, 5.997, 9.096, 9.777, 11.563, 3.765, 3.339;P〈0.05), but not at the other 3 locations (N1.0 mm, N2.0 mm N 2.5 mm)(F=2.889, 3.157, 2.194; P〉0.05). The CT was the same between NPDR CSME- group and control group (F=2.194, 3.157, 3.339, 2.889, 3.765, 3.459, 4.605, 5.997, 9.096, 9.777, 11.563;P〉0.05 ) . The CT was significant different (F=11.563, 9.777, 9.096;P〈0.05) between NPDR CSME- group and NPDR CSME+ group at 3 locations (T2.5 mm, T2.0 mm, T1.5 mm), but not other locations (F=2.194, 3.157, 3.339, 2.889, 3.765, 3.459, 4.605, 5.997; P〉0.05). Correlation analysis showed that in the control group (r=-0.096), NPDR CSME- group (r=0.026) and NPDR CSME+ group (r=-0.067) subfoveal CT and foveal retinal thickness was not correlated (P〉0.05). Conclusion NPDR macular edema patients have a thinner macular CT than control.
出处 《中华眼底病杂志》 CAS CSCD 北大核心 2014年第2期132-135,共4页 Chinese Journal of Ocular Fundus Diseases
关键词 脉络膜 体层摄影术 光学相干 糖尿病视网膜病变 Choroid Tomography, optical coherence Diabetic retinopathy
  • 相关文献

参考文献11

  • 1Nagaoka T, Kitaya N, Sugawara R, et al. Alteration of choroidal circulation in the foveal region in patients with type 2 diabetes [J]. Br J Ophthalmol, 2004,88 1060-1063.
  • 2Shin JW, Shin YU, Cho HY, et al. Measurement of choroidal thickness in normal eyes using 3D OCT-1000 spectral domain optical coherence tomography [J]. Korean J Ophthalmol, 2012, 26:255-259.
  • 3Manjunath V, Taha M, Fujimoto JG, et al. Choroidal thickness in normal eyes measured using Cirrus HD optical coherence tomography [J]. Am J Ophthalmol, 2010,150:325-329.
  • 4Querques G, Lattanzio R, Querques L, et al. Enhanced depth imaging optical coherence tomography in type 2 diabetes. Invest Ophthalmol Vis Sci, 2012,53 : 6017-6024.
  • 5曾婧,丁小燕,李加青,刘冉,马伟,潘间英,唐仕波.中国人黄斑区脉络膜厚度值及其影响因素分析[J].中华眼底病杂志,2011,27(5):450-453. 被引量:52
  • 6Wilkinson CP, Ferris FL ill, Klein RE, et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales [J]. Ophthalmology, 2003, 110:1677-1682.
  • 7Nickla DL, Wallman J. The multifunctional chor0id [J]. Prog Retin Eye Res, 2010,29:144-168.
  • 8Kim M, Kwon H J, Lee SC. Influence of mydriatics on choroidal thickness measurement using enhanced depth imaging-OCT [J]. Optom Vis Sci, 2012,89:1150-1155.
  • 9Tan CS, Ouyang Y, Ruiz H, et al. Diurnal variation of choroidal thickness in normal, healthy sub}ects measured by spectral domain optical coherence tomography [J]. Invest Ophthalmol Vis Sci, 2012,53 : 261-266.
  • 10Regatieri CV, Branchini L, Carmody J, et al. Choroidal thickness in patients with diabetic retinopathy analyzed by spectral-domain optical coherence tomography [J]. Retina,2012, 32 : 563-568.

二级参考文献14

  • 1Grossniklaus HE, Green WR. Choroidal neovaseularization. Am J Ophthalmol, 2004,137: 496-503.
  • 2Gomi F, Tano Y. Polypoidal choroidal vasculopathy and treatments. Curr Opin Ophthalmol, 2008,19 : 208-212.
  • 3Spaide RF, Hall L, Haas A, et al. lndocyanine green videoangiography of older patients with central chorioretinopathy. Retina, 1996,16 : 203-213.
  • 4Tesehner S, Noack J, Birngruber R, et al. Characterization of leakage activity in exudative chorioretinal disease with three- dimensional eonfoeal angiography. Ophthalmology, 2003, 110: 687-697.
  • 5Duke-Elder S, Abrams D. Pathological myopia// Duke-Elder S, Abrams D. System of ophthalmology: ophthalmic optics and refraction. 5th eds. London; Henry Kimpton,1970:300-362.
  • 6Harris A, Bingaman D, Ciulla TA, et al. Retina and ehoroidal blood flow in health and disease//Ryan SJ. Retina. 4th eds. Philadelphia: Elsevier, 2006 : 83-102.
  • 7Keane PA, Sadda SR. Imaging chorioretinal vascular disease. Eye (Lond) ,2010,24:422-427.
  • 8Grasbon T, Sehriever S, Hoops JP, et al. 3-D ultrasound. Initial experiences in various eye diseases. Ophthalmologe,2001, 98:88-93.
  • 9Chung SE, Kang SW, Lee JH, et al. Choroidal thickness in polypoidal choroidal vasculopathy and exudative age-related macular degeneration. Ophthalmology, 2011,118 : 840-845.
  • 10Benavente-Perez A, Hosking SL, Logan NS, et al. Reproducibility-repeatability of choroidal thickness calculation using optical coherence tomography. Optom Vis Sci, 2010,87 : 867-872.

共引文献51

同被引文献114

  • 1Francisco Rosa Stefanini,J Fernando Arevalo,Maurício Maia.Bevacizumab for the management of diabetic macular edema[J].World Journal of Diabetes,2013,4(2):19-26. 被引量:18
  • 2Ga Eun Cho,Hee Yun Cho,Yun Taek Kim.Change in subfoveal choroidal thickness after argon laser panretinal photocoagulation[J].International Journal of Ophthalmology(English edition),2013,6(4):505-509. 被引量:15
  • 3Lukas Reznicek,Marcus Kernt,Christos Haritoglou,Michael Ulbig,Anselm Kampik,Aljoscha S Neubauer.Correlation of leaking microaneurysms with retinal thickening in diabetic retinopathy[J].International Journal of Ophthalmology(English edition),2011,4(3):269-271. 被引量:2
  • 4Harris A,Bingaman D,Ciulla TA,et al.Retina and ehoroidal blood flow in health and disease.In:Ryan SJ.Retina.4th ed.Philadelphia:Elsevier,2006:83-102.
  • 5Guyer DR,Schachat AP,Green WR.The choroid:structural considerations.In:Ryan SJ.Retina.4th ed.Philadelphia:Elsevier,2006:34-42.
  • 6Margolis R,Spaide RF.A pilot study of enhanced depth imaging optical coherence tomography of the choroid in normal eyes.Am J Ophthalmol,2009,147(5):811-815.
  • 7Spaide RF,Koizumi H,Pozzoni MC.Enhanced depth imaging spectral-domain opticaI coherence tomography.Am J Ophthalmol,2008,146(4):496-500.
  • 8Ikuno Y,Kawaguchi K,Nouchi T,et al.Choroidal thickness inhealthy japanese subjects.Invest Ophthalmol Vis Sci,2010,51(4):2173-2176.
  • 9Ding X,Li J,Zeng J,et al.Choroidal thickness in healthy Chinese subjects.Invest Ophthalmol Vis Sci,2011,52 (13):9555-9560.
  • 10Hareh SS.In vivo circulation and its watershed zones.Eye,1990,4(2):273-289.

引证文献11

二级引证文献71

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部